Clinical Application of an Innovative Multiplex-Fluorescent-Labeled STRs Assay for Prader-Willi Syndrome and Angelman Syndrome.
Prader-Willi syndrome (PWS) and Angelman syndrome (AS) are two clinically distinct neurodevelopmental disorders caused by absence of paternally or maternally expressed imprinted genes on chr15q11.2-q13.3. Three mechanisms are known to be involved in the pathogenesis: microdeletions, uniparental diso...
Main Authors: | Kaihui Zhang, Shu Liu, Bing Feng, Yali Yang, Haiyan Zhang, Rui Dong, Yi Liu, Zhongtao Gai |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4739598?pdf=render |
Similar Items
-
Prader–Willi Syndrome with Angelman Syndrome in the Offspring
by: Donatella Greco, et al.
Published: (2021-05-01) -
Prader-Willi and Angelman Syndromes: Mechanisms and Management
by: Ma VK, et al.
Published: (2023-04-01) -
Practice guidelines for the molecular analysis of Prader-Willi and Angelman syndromes
by: Birch Rachael, et al.
Published: (2010-05-01) -
A Streamlined Approach to Prader-Willi and Angelman Syndrome Molecular Diagnostics
by: Samuel P. Strom, et al.
Published: (2021-05-01) -
Genetic testing for Prader-Willi syndrome and Angelman syndrome in the clinical practice of Guangdong Province, China
by: Chang Liu, et al.
Published: (2019-02-01)